Microscopic peptide droplets reduce colorectal tumor growth in mice
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of…
WHO launches PARTNERS clinical trial for Bundibugyo virus treatments
In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the…
Monoclonal antibody shows promise for treating acute respiratory distress syndrome
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or…
New drug combo may preserve muscle during weight loss
(NewsNation) — A recent trial suggests apitegromab, when used alongside tirzepatide, may help preserve lean body mass while…
Heart tissue repair drug may also help repair and regenerate damaged kidney tissues
A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also…
Apitegromab helps tirzepatide users lose fat while preserving lean mass
A phase 2 trial suggests that blocking myostatin activation may help people taking tirzepatide retain more lean body…
Chronic inflammation shapes cancer progression and immunotherapy response
Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs,…
Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in children
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows…
Northwestern team develops antibody to expose hidden pancreatic cancer cells
Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have…
Bispecific Antibodies Market – Global Forecast 2025-2032,
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) — The “Bispecific Antibodies Market – Global Forecast 2025-2032” report has been…
NIH awards $3.4 million to support research on Crimean-Congo hemorrhagic fever virus
Crimean-Congo hemorrhagic fever virus, or CCHFV, is a biosafety level 4 pathogen and a Category A bioterrorism agent,…